Welcome to the international HTA database

Showing [21894 Records] Selected Records [0 Hits] [Clear]

Year	Source	Title
2020	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Cervical spine syndrome: the impact of the duration and frequency of physiotherapy on treatment success]
2011	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Cessation of smoking in essential hypertension - Rapid report]
2006	Danish Centre for Evaluation and Health Technology Assessment (DACEHTA)	[Cetuximah given in combination for patients with colorectal cancer]
2014	Institut national d'excellence en sante et en services sociaux (INESSS)	[Change in the Proton Pump Inhibitors (PPI) terms for coverage: a follow-up]
2018	Basque Office for Health Technology Assessment (OSTEBA)	[Checklist for ethical and legal domains analysis]
2024	Institut national d'excellence en sante et en services sociaux (INESSS)	[Checklist: non-physician prescribers' scope of practice]
2012	Institute for Clinical Effectiveness and Health Policy (IECS)	[Chemoembolization and radioembolization for the treatment of liver metastases]
2002	Danish Centre for Evaluation and Health Technology Assessment (DACEHTA)	[Chlamydia screening with home testing - a health technology assessment]
2014	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Cholic acid - Assessment according to §35a (para. 1., sentence 10) Social Code Book V (dossier assessment)]
2012	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Cholinesterase inhibitors in Alzheimer's disease - supplementary commission: rivastigmine patches and galantamine]
2008	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Cholinesterase inhibitors in Alzheimer's disease]
2011	Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA)	[ChondroCelect® in patients with knee cartilage injury]
2013	Institute for Clinical Effectiveness and Health Policy (IECS)	[Chromosomal microarrays for the etiologic diagnosis in patients with intellectual disability, developmental delay or autism spectrum]
2010	Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS)	[Chronic fatigue syndrome: state of the evidence and assessment of intervention modalities in Quebec]
2002	Danish Centre for Evaluation and Health Technology Assessment (DACEHTA)	[Chronic hepatitis C. Combination therapy IFN and ribavirin]
2010	Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA)	[Chronic low back pain: the appropriate use of diagnostic imaging procedures]
2005	Danish Centre for Evaluation and Health Technology Assessment (DACEHTA)	[Chronic periodontitis - prevention, diagnosis and treatment]
2014	The Swedish Council on Health Technology Assessment (SBU)	[Chronic ulcers in the elderly – prevention and treatment]
2013	Institute for Clinical Effectiveness and Health Policy (IECS)	[Cidofovir for the treatment of recurrent respiratory papillomatosis]
2010	The Swedish Council on Health Technology Assessment (SBU)	[Cilostazol for treatment of intermittent claudication]
2023	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Ciltacabtagene autoleucel (multiple myeloma) - Assessment according to §35a (para. 1, sentence 11) Social Code Book V]
2024	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Cipaglucosidase alfa (Pompe disease) – Addendum to Project A23-79]
2023	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Cipaglucosidase alfa (Pompe disease) – Benefit assessment according to § 35a Social Code Book (SGB) V]
2016	Institut national d'excellence en sante et en services sociaux (INESSS)	[Circulating tumour cells in breast cancer: clinical use of the CellSearch® test]
2018	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Cladribine (multiple sclerosis) - Benefit assessment according to §35a Social Code Book (SGB) V]
2010	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	[Classification of disease severity for neuro- and trauma rehabilitation Part 3: Status quo in Austria]
2008	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	[Clavicular fractures - a systematic review about efficacy and safety of different treatment options]
2019	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Cleft lip and palate: does using the nasoalveolar molding method before surgery lead to better results?]
2020	Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)	[Clinical Efectiveness of Newborn Screening for Inborn Errors of Metabolism by MS/ MS. Update and pilot study assessment: Maple Syrup Urine Disease; Isovaleric Acidaemia; Homocystinuria]
2012	German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI)	[Clinical effectiveness and cost-effectiveness of central venous catheters treated with minocycline and rifampicin in preventing bloodstream infections in intensive care patients]
2014	German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI)	[Clinical effectiveness and cost-effectiveness of fissure sealants in children and adolescents with a high caries risk]
2017	Basque Office for Health Technology Assessment (OSTEBA)	[Clinical effectiveness and cost-effectiveness of non-invasive telemonitoring on patients with heart failure]
2014	National Evidence-based Healthcare Collaborating Agency (NECA)	[Clinical effectiveness and safety of robotic surgery]
2005	Unit of Health Economics and Technology Assessment in Health Care (HunHTA)	[Clinical effectiveness of carvedilol in comparison to -blockers, systematic review of the clinical and economic literature]
2005	Unit of Health Economics and Technology Assessment in Health Care (HunHTA)	[Clinical effectiveness of indapamide; systematic review of the clinical and economic literature]
2007	Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)	[Clinical effectiveness of neonatal screening for inborn errors of metabolism using tandem mass spectrometry. Systematic Review]
2013	Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)	[Clinical effectiveness of newborn screening for inborn errors of metabolism using mass spectrometry: Maple Syrup Urine Disease, Homocystinuria, Glutaric Aciduria Type I, Isovaleric Acidaemia, Long-chain 3-Hydroxyacyl CoA Dehydrogenase Deficiency]
2015	Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)	[Clinical effectiveness of newborn screening for inborn errors of metabolism using mass spectrometry. Part III: carnitine uptake deficiency (CUD); short-chain acyl-CoA dehydrogenase deficiency (SCADD); very long-chain acyl-CoA dehydrogenase deficiency (VLCADD)]
2015	Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)	[Clinical effectiveness of newborn screening for inborn errors of metabolism using mass spectrometry. Part IV: Beta-kethiolase deficiency (BKT); 3-Hydroxy-3-methyl glutaric aciduria (HMG)]
2015	Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)	[Clinical effectiveness of newborn screening for inborn errors of metabolism using mass spectrometry. Part IV: β-ketothiolase deficiency (BKT); 3-hydroxy-3-methyl glutaric aciduria (HMG)]
2014	Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)	[Clinical effectiveness of newborn screening for inborn errors of metabolism. Part II: Methylmalonic acidemia, Propionic acidemia, Tyrosinemia type I]
2018	Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)	[Clinical effectiveness of newborn screening for severe combined immunodeficiency]
2009	Andalusian Health Technology Assessment Area (AETSA)	[Clinical effectiveness of ozone therapies]
2009	Andalusian Health Technology Assessment Area (AETSA)	[Clinical effectiveness of ozone therapies]
2020	Agencia de Evaluacion de Tecnologias Sanitarias (AETS)	[Clinical effectiveness of pulse oximetry for neonatal screening of critical congenital heart diseases]
2021	Health Sciences Institute in Aragon (IACS)	[Clinical effectiveness of sFlt-1 to PlGF ratio tests for the evaluation of preeclampsia]
2022	Andalusian Health Technology Assessment Area (AETSA)	[Clinical effectiveness, safety, and economic assessment of mass screening for hepatitis C. Systematic review]
2016	Institut national d'excellence en sante et en services sociaux (INESSS)	[Clinical guides in antibiotic treatment – 1st series (update)]
2012	Institut national d'excellence en sante et en services sociaux (INESSS)	[Clinical guides in antibiotic treatment, 2nd series]
2007	Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)	[Clinical impact of capsule endoscopy in obscure gastrointestinal bleeding. Systematic review]
2017	Basque Office for Health Technology Assessment (OSTEBA)	[Clinical Practice Guideline about breastfeeding]
2010	Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA)	[Clinical practice guideline for attention deficit hyperactivity disorder (ADHD) in children and adolescents]
2001	Andalusian Health Technology Assessment Area (AETSA)	[Clinical practice guideline for medical management of otitis media in childhood]
2012	Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA)	[Clinical practice guideline of care for people with multiple sclerosis]
2010	Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA)	[Clinical practice guideline on acute bronchiolitis]
2021	Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)	[Clinical Practice Guideline on adult's palliative care]
2010	Basque Office for Health Technology Assessment (OSTEBA)	[Clinical practice guideline on assistance at normal childbirth]
2005	Basque Office for Health Technology Assessment (OSTEBA)	[Clinical practice guideline on asthma]
2011	Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA)	[Clinical practice guideline on borderline personality disorders]
2015	Basque Office for Health Technology Assessment (OSTEBA)	[Clinical Practice Guideline on Childhood Asthma]
2014	Andalusian Health Technology Assessment Area (AETSA)	[Clinical practice guideline on intravenous therapy with temporary devices in adults]
2007	Basque Office for Health Technology Assessment (OSTEBA)	[Clinical practice guideline on low back pain]
2010	Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA)	[Clinical practice guideline on osteoporosis and prevention of fragility fractures]
2008	Basque Office for Health Technology Assessment (OSTEBA)	[Clinical practice guideline on palliative care]
2012	Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)	[Clinical Practice Guideline on prevention and management of suicidal behaviour]
2011	Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA)	[Clinical Practice Guideline on the care for people with alzheimer's disease and dementia]
2010	Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA)	[Clinical practice guideline on the diagnostic, treatment and prevention of tuberculosis]
2007	Basque Office for Health Technology Assessment (OSTEBA)	[Clinical practice guideline on the management of head injury in the field of extra and initial hospital care]
2017	Andalusian Health Technology Assessment Area (AETSA)	[Clinical practice guideline on the management of vasomotor and vaginal symptoms associated with menopause and postmenopause]
2012	Basque Office for Health Technology Assessment (OSTEBA)	[Clinical practice guideline on type 1 diabetes]
2008	Basque Office for Health Technology Assessment (OSTEBA)	[Clinical practice guideline on type 2 diabetes]
2017	Andalusian Health Technology Assessment Area (AETSA)	[Clinical practice guidelines for hemotherapy. Brief report]
2016	Institut national d'excellence en sante et en services sociaux (INESSS)	[Clinical practice guidelines for the rehabilitation of adults having sustained a moderate to severe traumatic brain injury: development process and recommendations]
2008	Basque Office for Health Technology Assessment (OSTEBA)	[Clinical practice guidelines on arterial hypertension (2007 update)]
2017	Basque Office for Health Technology Assessment (OSTEBA)	[Clinical practice guidelines on lipid management as a cardiovascular risk factor]
2018	Andalusian Health Technology Assessment Area (AETSA)	[Clinical practice guidelines on severe mental disorder]
2020	Basque Office for Health Technology Assessment (OSTEBA)	[Clinical Practice Guidelines on the diagnosis and treatment of non-serious blunt chest trauma]
2015	National Evidence-based Healthcare Collaborating Agency (NECA)	[Clinical safety and effectiveness of robotic surgery (2)]
2021	Andalusian Health Technology Assessment Area (AETSA)	[Clinical utility of optical coherence tomography angiography in exudative age-related macular degeneration management]
2013	Haute Autorite de sante (HAS)	[Clinical utility of the measurement of vitamin D]
2012	National Evidence-based Healthcare Collaborating Agency (NECA)	[Clinically relevant venous thromboembolism following hip and knee arthroplasty]
2009	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Clopidogrel plus acetylsalicylic acid in acute coronary syndrome]
2006	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Clopidogrel versus acetylsalicylic acid for the secondary prevention of vascular diseases]
2023	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Clopidogrel, prasugrel, and ticagrelor for the prevention of atherothrombotic events in acute coronary syndrome]
2019	Basque Office for Health Technology Assessment (OSTEBA)	[Closed vs open systems for the preparation and administration of cytostatic and other hazardous drugs (NIOSH Group 1): analysis of the scientific evidence, costs and organisational requirements]
2012	Institute for Clinical Effectiveness and Health Policy (IECS)	[CO2 Laser surgery in patients with otosclerosis]
2009	Committee for New Health Technology Assessment (CNHTA)	[CoaguChek XS PT TEST]
2020	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Cobicistat (HIV infection) - Benefit assessment according to §35a Social Code Book V]
2016	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Cobimetinib - Benefit assessment according to §35a Social Code Book V]
2016	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Cobimetinib: addendum to commission A15-52]
2008	Center for Medical Technology Assessment (CMT)	[Cognitive assistive technologies for persons with dementia - cost-effectiveness and quality of prescription process]
2021	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Cognitive behavioural therapy for insomnia - Evidence report for the S3 guideline on non-restorative sleep/sleep disorders - Insomnia in adults]
2015	Institute for Clinical Effectiveness and Health Policy (IECS)	[Cognitive rehabilitation in cognitive deficit secondary to stroke]
2018	Institute for Clinical Effectiveness and Health Policy (IECS)	[Cognitive rehabilitation in secondary cognitive impairment]
2006	Danish Centre for Evaluation and Health Technology Assessment (DACEHTA)	[Coherent monitoring and follow-up of pregnant women with a heart disease - a Health Technology Assessment]
2008	Committee for New Health Technology Assessment (CNHTA)	[COL2A1 gene, mutation[sequencing]]
2008	Committee for New Health Technology Assessment (CNHTA)	[COL3A1 gene mutation analysis]
2023	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Cold plasma in wound therapy (2nd addendum to Commission E21-03)]
2021	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Cold plasma in wound therapy (Addendum to Commission E21-03)]
2023	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Cold plasma in wound therapy]